 | • レポートコード：GIR201114122 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、121ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、嚢胞性線維症治療の世界市場を調査対象にし、嚢胞性線維症治療の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（経口、注射）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Actavis、Arcturus Therapeutics、Novartis、F. Hoffmann-La Roche、Anthera Pharmaceuticals、Gilead Sciences、Chiesi Farmaceutici、Abbott、Vertex Pharmaceuticals、Boehringer Ingelheim、Merck Sharp & Dohme、PharmaSwiss、Corbus Pharmaceuticals、Proteostasis Therapeutics、Neovii Biotech、Johnson & Johnson、Genzyme、Pharmaxis、Novo Nordisk、Insmed、PTC Therapeutics、United Medical、Venus Remedies ・企業別売上、市場シェア ・嚢胞性線維症治療の地域別市場分析 ・嚢胞性線維症治療の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・嚢胞性線維症治療のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・嚢胞性線維症治療のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・嚢胞性線維症治療の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・嚢胞性線維症治療の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・嚢胞性線維症治療の種類別市場規模2015-2020：経口、注射 ・嚢胞性線維症治療の用途別市場規模2015-2020：病院、クリニック、その他 ・嚢胞性線維症治療の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Cystic Fibrosis Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Cystic Fibrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cystic Fibrosis Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cystic Fibrosis Treatment market has been segmented into:
Oral
Injection
By Application, Cystic Fibrosis Treatment has been segmented into:
Hospitals
Clinics
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cystic Fibrosis Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level Cystic Fibrosis Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cystic Fibrosis Treatment market.
The report offers in-depth assessment of the growth and other aspects of the Cystic Fibrosis Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Cystic Fibrosis Treatment Market Share Analysis
Cystic Fibrosis Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cystic Fibrosis Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cystic Fibrosis Treatment sales, revenue and market share for each player covered in this report.
The major players covered in Cystic Fibrosis Treatment are:
Actavis
Arcturus Therapeutics
Novartis
F. Hoffmann-La Roche
Anthera Pharmaceuticals
Gilead Sciences
Chiesi Farmaceutici
Abbott
Vertex Pharmaceuticals
Boehringer Ingelheim
Merck Sharp & Dohme
PharmaSwiss
Corbus Pharmaceuticals
Proteostasis Therapeutics
Neovii Biotech
Johnson & Johnson
Genzyme
Pharmaxis
Novo Nordisk
Insmed
PTC Therapeutics
United Medical
Venus Remedies
Table of Contents
1 Cystic Fibrosis Treatment Market Overview
1.1 Product Overview and Scope of Cystic Fibrosis Treatment
1.2 Classification of Cystic Fibrosis Treatment by Type
1.2.1 Global Cystic Fibrosis Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Cystic Fibrosis Treatment Revenue Market Share by Type in 2019
1.2.3 Oral
1.2.4 Injection
1.3 Global Cystic Fibrosis Treatment Market by Application
1.3.1 Overview: Global Cystic Fibrosis Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Cystic Fibrosis Treatment Market by Regions
1.4.1 Global Cystic Fibrosis Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Cystic Fibrosis Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Cystic Fibrosis Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Cystic Fibrosis Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cystic Fibrosis Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Cystic Fibrosis Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cystic Fibrosis Treatment Status and Prospect (2015-2025)
2 Company Profiles
2.1 Actavis
2.1.1 Actavis Details
2.1.2 Actavis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Actavis SWOT Analysis
2.1.4 Actavis Product and Services
2.1.5 Actavis Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arcturus Therapeutics
2.2.1 Arcturus Therapeutics Details
2.2.2 Arcturus Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Arcturus Therapeutics SWOT Analysis
2.2.4 Arcturus Therapeutics Product and Services
2.2.5 Arcturus Therapeutics Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis SWOT Analysis
2.3.4 Novartis Product and Services
2.3.5 Novartis Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche SWOT Analysis
2.4.4 F. Hoffmann-La Roche Product and Services
2.4.5 F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Anthera Pharmaceuticals
2.5.1 Anthera Pharmaceuticals Details
2.5.2 Anthera Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Anthera Pharmaceuticals SWOT Analysis
2.5.4 Anthera Pharmaceuticals Product and Services
2.5.5 Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Gilead Sciences
2.6.1 Gilead Sciences Details
2.6.2 Gilead Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Gilead Sciences SWOT Analysis
2.6.4 Gilead Sciences Product and Services
2.6.5 Gilead Sciences Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 Chiesi Farmaceutici
2.7.1 Chiesi Farmaceutici Details
2.7.2 Chiesi Farmaceutici Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Chiesi Farmaceutici SWOT Analysis
2.7.4 Chiesi Farmaceutici Product and Services
2.7.5 Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abbott SWOT Analysis
2.8.4 Abbott Product and Services
2.8.5 Abbott Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 Vertex Pharmaceuticals
2.9.1 Vertex Pharmaceuticals Details
2.9.2 Vertex Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Vertex Pharmaceuticals SWOT Analysis
2.9.4 Vertex Pharmaceuticals Product and Services
2.9.5 Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Boehringer Ingelheim
2.10.1 Boehringer Ingelheim Details
2.10.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Boehringer Ingelheim SWOT Analysis
2.10.4 Boehringer Ingelheim Product and Services
2.10.5 Boehringer Ingelheim Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.11 Merck Sharp & Dohme
2.11.1 Merck Sharp & Dohme Details
2.11.2 Merck Sharp & Dohme Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Merck Sharp & Dohme SWOT Analysis
2.11.4 Merck Sharp & Dohme Product and Services
2.11.5 Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.12 PharmaSwiss
2.12.1 PharmaSwiss Details
2.12.2 PharmaSwiss Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 PharmaSwiss SWOT Analysis
2.12.4 PharmaSwiss Product and Services
2.12.5 PharmaSwiss Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.13 Corbus Pharmaceuticals
2.13.1 Corbus Pharmaceuticals Details
2.13.2 Corbus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Corbus Pharmaceuticals SWOT Analysis
2.13.4 Corbus Pharmaceuticals Product and Services
2.13.5 Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.14 Proteostasis Therapeutics
2.14.1 Proteostasis Therapeutics Details
2.14.2 Proteostasis Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Proteostasis Therapeutics SWOT Analysis
2.14.4 Proteostasis Therapeutics Product and Services
2.14.5 Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.15 Neovii Biotech
2.15.1 Neovii Biotech Details
2.15.2 Neovii Biotech Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Neovii Biotech SWOT Analysis
2.15.4 Neovii Biotech Product and Services
2.15.5 Neovii Biotech Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.16 Johnson & Johnson
2.16.1 Johnson & Johnson Details
2.16.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Johnson & Johnson SWOT Analysis
2.16.4 Johnson & Johnson Product and Services
2.16.5 Johnson & Johnson Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.17 Genzyme
2.17.1 Genzyme Details
2.17.2 Genzyme Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Genzyme SWOT Analysis
2.17.4 Genzyme Product and Services
2.17.5 Genzyme Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.18 Pharmaxis
2.18.1 Pharmaxis Details
2.18.2 Pharmaxis Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Pharmaxis SWOT Analysis
2.18.4 Pharmaxis Product and Services
2.18.3 Pharmaxis Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.19 Novo Nordisk
2.19.1 Novo Nordisk Details
2.19.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Novo Nordisk SWOT Analysis
2.19.4 Novo Nordisk Product and Services
2.19.5 Novo Nordisk Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.20 Insmed
2.20.1 Insmed Details
2.20.2 Insmed Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Insmed SWOT Analysis
2.20.4 Insmed Product and Services
2.20.5 Insmed Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.21 PTC Therapeutics
2.21.1 PTC Therapeutics Details
2.21.2 PTC Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 PTC Therapeutics SWOT Analysis
2.21.4 PTC Therapeutics Product and Services
2.21.5 PTC Therapeutics Cystic Fibrosis Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.22 United Medical
2.23 Venus Remedies
3 Market Competition, by Players
3.1 Global Cystic Fibrosis Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Cystic Fibrosis Treatment Players Market Share
3.2.2 Top 10 Cystic Fibrosis Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Cystic Fibrosis Treatment Revenue and Market Share by Regions
4.2 North America Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
4.5 South America Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
5 North America Cystic Fibrosis Treatment Revenue by Countries
5.1 North America Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
5.2 USA Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
6 Europe Cystic Fibrosis Treatment Revenue by Countries
6.1 Europe Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
6.2 Germany Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
6.3 UK Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
6.4 France Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Cystic Fibrosis Treatment Revenue by Countries
7.1 Asia-Pacific Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
7.2 China Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
7.5 India Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
8 South America Cystic Fibrosis Treatment Revenue by Countries
8.1 South America Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
8.2 Brazil Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Cystic Fibrosis Treatment by Countries
9.1 Middle East & Africa Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Cystic Fibrosis Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global Cystic Fibrosis Treatment Market Forecast by Type (2019-2024)
10.3 Oral Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
11 Global Cystic Fibrosis Treatment Market Segment by Application
11.1 Global Cystic Fibrosis Treatment Revenue Market Share by Application (2015-2020)
11.2 Cystic Fibrosis Treatment Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Cystic Fibrosis Treatment Market Size Forecast (2021-2025)
12.1 Global Cystic Fibrosis Treatment Market Size Forecast (2021-2025)
12.2 Global Cystic Fibrosis Treatment Market Forecast by Regions (2021-2025)
12.3 North America Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
12.4 Europe Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
12.6 South America Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Cystic Fibrosis Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cystic Fibrosis Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cystic Fibrosis Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Cystic Fibrosis Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Actavis Corporate Information, Location and Competitors
Table 6. Actavis Cystic Fibrosis Treatment Major Business
Table 7. Actavis Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 8. Actavis SWOT Analysis
Table 9. Actavis Cystic Fibrosis Treatment Product and Solutions
Table 10. Actavis Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Arcturus Therapeutics Corporate Information, Location and Competitors
Table 12. Arcturus Therapeutics Cystic Fibrosis Treatment Major Business
Table 13. Arcturus Therapeutics Cystic Fibrosis Treatment Total Revenue (USD Million) (2018-2019)
Table 14. Arcturus Therapeutics SWOT Analysis
Table 15. Arcturus Therapeutics Cystic Fibrosis Treatment Product and Solutions
Table 16. Arcturus Therapeutics Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis Corporate Information, Location and Competitors
Table 18. Novartis Cystic Fibrosis Treatment Major Business
Table 19. Novartis Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 20. Novartis SWOT Analysis
Table 21. Novartis Cystic Fibrosis Treatment Product and Solutions
Table 22. Novartis Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. F. Hoffmann-La Roche Corporate Information, Location and Competitors
Table 24. F. Hoffmann-La Roche Cystic Fibrosis Treatment Major Business
Table 25. F. Hoffmann-La Roche Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 26. F. Hoffmann-La Roche SWOT Analysis
Table 27. F. Hoffmann-La Roche Cystic Fibrosis Treatment Product and Solutions
Table 28. F. Hoffmann-La Roche Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Anthera Pharmaceuticals Corporate Information, Location and Competitors
Table 30. Anthera Pharmaceuticals Cystic Fibrosis Treatment Major Business
Table 31. Anthera Pharmaceuticals Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 32. Anthera Pharmaceuticals SWOT Analysis
Table 33. Anthera Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions
Table 34. Anthera Pharmaceuticals Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Gilead Sciences Corporate Information, Location and Competitors
Table 36. Gilead Sciences Cystic Fibrosis Treatment Major Business
Table 37. Gilead Sciences Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 38. Gilead Sciences SWOT Analysis
Table 39. Gilead Sciences Cystic Fibrosis Treatment Product and Solutions
Table 40. Gilead Sciences Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Chiesi Farmaceutici Corporate Information, Location and Competitors
Table 42. Chiesi Farmaceutici Cystic Fibrosis Treatment Major Business
Table 43. Chiesi Farmaceutici Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 44. Chiesi Farmaceutici SWOT Analysis
Table 45. Chiesi Farmaceutici Cystic Fibrosis Treatment Product and Solutions
Table 46. Chiesi Farmaceutici Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Abbott Corporate Information, Location and Competitors
Table 48. Abbott Cystic Fibrosis Treatment Major Business
Table 49. Abbott Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 50. Abbott SWOT Analysis
Table 51. Abbott Cystic Fibrosis Treatment Product and Solutions
Table 52. Abbott Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Vertex Pharmaceuticals Corporate Information, Location and Competitors
Table 54. Vertex Pharmaceuticals Cystic Fibrosis Treatment Major Business
Table 55. Vertex Pharmaceuticals Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 56. Vertex Pharmaceuticals SWOT Analysis
Table 57. Vertex Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions
Table 58. Vertex Pharmaceuticals Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 60. Boehringer Ingelheim Cystic Fibrosis Treatment Major Business
Table 61. Boehringer Ingelheim Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 62. Boehringer Ingelheim SWOT Analysis
Table 63. Boehringer Ingelheim Cystic Fibrosis Treatment Product and Solutions
Table 64. Boehringer Ingelheim Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Merck Sharp & Dohme Corporate Information, Location and Competitors
Table 66. Merck Sharp & Dohme Cystic Fibrosis Treatment Major Business
Table 67. Merck Sharp & Dohme Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 68. Merck Sharp & Dohme SWOT Analysis
Table 69. Merck Sharp & Dohme Cystic Fibrosis Treatment Product and Solutions
Table 70. Merck Sharp & Dohme Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. PharmaSwiss Corporate Information, Location and Competitors
Table 72. PharmaSwiss Cystic Fibrosis Treatment Major Business
Table 73. PharmaSwiss Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 74. PharmaSwiss SWOT Analysis
Table 75. PharmaSwiss Cystic Fibrosis Treatment Product and Solutions
Table 76. PharmaSwiss Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Corbus Pharmaceuticals Corporate Information, Location and Competitors
Table 78. Corbus Pharmaceuticals Cystic Fibrosis Treatment Major Business
Table 79. Corbus Pharmaceuticals Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 80. Corbus Pharmaceuticals SWOT Analysis
Table 81. Corbus Pharmaceuticals Cystic Fibrosis Treatment Product and Solutions
Table 82. Corbus Pharmaceuticals Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Proteostasis Therapeutics Corporate Information, Location and Competitors
Table 84. Proteostasis Therapeutics Cystic Fibrosis Treatment Major Business
Table 85. Proteostasis Therapeutics Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 86. Proteostasis Therapeutics SWOT Analysis
Table 87. Proteostasis Therapeutics Cystic Fibrosis Treatment Product and Solutions
Table 88. Proteostasis Therapeutics Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Neovii Biotech Corporate Information, Location and Competitors
Table 90. Neovii Biotech Cystic Fibrosis Treatment Major Business
Table 91. Neovii Biotech Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 92. Neovii Biotech SWOT Analysis
Table 93. Neovii Biotech Cystic Fibrosis Treatment Product and Solutions
Table 94. Neovii Biotech Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Johnson & Johnson Corporate Information, Location and Competitors
Table 96. Johnson & Johnson Cystic Fibrosis Treatment Major Business
Table 97. Johnson & Johnson Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 98. Johnson & Johnson SWOT Analysis
Table 99. Johnson & Johnson Cystic Fibrosis Treatment Product and Solutions
Table 100. Johnson & Johnson Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Genzyme Corporate Information, Location and Competitors
Table 102. Genzyme Cystic Fibrosis Treatment Major Business
Table 103. Genzyme Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 104. Genzyme SWOT Analysis
Table 105. Genzyme Cystic Fibrosis Treatment Product and Solutions
Table 106. Genzyme Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 107. Pharmaxis Cystic Fibrosis Treatment Type and Application
Table 108. Pharmaxis Cystic Fibrosis Treatment Major Business
Table 109. Pharmaxis Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 110. Pharmaxis SWOT Analysis
Table 111. Pharmaxis Cystic Fibrosis Treatment Product and Solutions
Table 112. Pharmaxis Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 113. Novo Nordisk Corporate Information, Location and Competitors
Table 114. Novo Nordisk Cystic Fibrosis Treatment Major Business
Table 115. Novo Nordisk Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 116. Novo Nordisk SWOT Analysis
Table 117. Novo Nordisk Cystic Fibrosis Treatment Product and Solutions
Table 118. Novo Nordisk Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 119. Insmed Corporate Information, Location and Competitors
Table 120. Insmed Cystic Fibrosis Treatment Major Business
Table 121. Insmed Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 122. Insmed SWOT Analysis
Table 123. Insmed Cystic Fibrosis Treatment Product and Solutions
Table 124. Insmed Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 125. PTC Therapeutics Corporate Information, Location and Competitors
Table 126. PTC Therapeutics Cystic Fibrosis Treatment Major Business
Table 127. PTC Therapeutics Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 128. PTC Therapeutics SWOT Analysis
Table 129. PTC Therapeutics Cystic Fibrosis Treatment Product and Solutions
Table 130. PTC Therapeutics Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 131. United Medical Corporate Information, Location and Competitors
Table 132. United Medical Cystic Fibrosis Treatment Major Business
Table 133. United Medical Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 134. United Medical SWOT Analysis
Table 135. United Medical Cystic Fibrosis Treatment Product and Solutions
Table 136. United Medical Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 137. Venus Remedies Corporate Information, Location and Competitors
Table 138. Venus Remedies Cystic Fibrosis Treatment Major Business
Table 139. Venus Remedies Cystic Fibrosis Treatment Total Revenue (USD Million) (2017-2018)
Table 140. Venus Remedies SWOT Analysis
Table 141. Venus Remedies Cystic Fibrosis Treatment Product and Solutions
Table 142. Venus Remedies Cystic Fibrosis Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 143. Global Cystic Fibrosis Treatment Revenue (Million USD) by Players (2015-2020)
Table 144. Global Cystic Fibrosis Treatment Revenue Share by Players (2015-2020)
Table 145. Global Cystic Fibrosis Treatment Revenue (Million USD) by Regions (2015-2020)
Table 146. Global Cystic Fibrosis Treatment Revenue Market Share by Regions (2015-2020)
Table 147. North America Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
Table 148. North America Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 149. Europe Cystic Fibrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 150. Asia-Pacific Cystic Fibrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 151. South America Cystic Fibrosis Treatment Revenue by Countries (2015-2020)
Table 152. South America Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 153. Middle East and Africa Cystic Fibrosis Treatment Revenue (Million USD) by Countries (2015-2020)
Table 154. Middle East and Africa Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Table 155. Global Cystic Fibrosis Treatment Revenue (Million USD) by Type (2015-2020)
Table 156. Global Cystic Fibrosis Treatment Revenue Share by Type (2015-2020)
Table 157. Global Cystic Fibrosis Treatment Revenue Forecast by Type (2021-2025)
Table 158. Global Cystic Fibrosis Treatment Revenue by Application (2015-2020)
Table 159. Global Cystic Fibrosis Treatment Revenue Share by Application (2015-2020)
Table 160. Global Cystic Fibrosis Treatment Revenue Forecast by Application (2021-2025)
Table 161. Global Cystic Fibrosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Cystic Fibrosis Treatment Picture
Figure 2. Global Cystic Fibrosis Treatment Revenue Market Share by Type in 2019
Figure 3. Oral Picture
Figure 4. Injection Picture
Figure 5. Cystic Fibrosis Treatment Revenue Market Share by Application in 2019
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Other Picture
Figure 9. Global Cystic Fibrosis Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Cystic Fibrosis Treatment Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Cystic Fibrosis Treatment Revenue Market Share in 2019
Figure 18. Global Top 10 Players Cystic Fibrosis Treatment Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Cystic Fibrosis Treatment Revenue Market Share by Regions (2015-2020)
Figure 22. Global Cystic Fibrosis Treatment Revenue Market Share by Regions in 2018
Figure 23. North America Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Europe Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 26. South America Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 28. North America Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 29. North America Cystic Fibrosis Treatment Revenue Market Share by Countries in 2019
Figure 30. USA Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Canada Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 33. Europe Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Cystic Fibrosis Treatment Revenue Market Share by Countries in 2019
Figure 35. Germany Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 36. UK Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 37. France Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Russia Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Italy Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Cystic Fibrosis Treatment Revenue Market Share by Countries in 2019
Figure 42. China Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Japan Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 44. Korea Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 45. India Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 47. South America Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 48. South America Cystic Fibrosis Treatment Revenue Market Share by Countries in 2019
Figure 49. Brazil Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Cystic Fibrosis Treatment Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Cystic Fibrosis Treatment Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 54. UAE Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Cystic Fibrosis Treatment Revenue and Growth Rate (2015-2020)
Figure 57. Global Cystic Fibrosis Treatment Revenue Share by Type (2015-2020)
Figure 58. Global Cystic Fibrosis Treatment Revenue Share by Type in 2019
Figure 59. Global Cystic Fibrosis Treatment Market Share Forecast by Type (2021-2025)
Figure 60. Global Oral Revenue Growth Rate (2015-2020)
Figure 61. Global Injection Revenue Growth Rate (2015-2020)
Figure 62. Global Cystic Fibrosis Treatment Revenue Share by Application (2015-2020)
Figure 63. Global Cystic Fibrosis Treatment Revenue Share by Application in 2019
Figure 64. Global Cystic Fibrosis Treatment Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global Clinics Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Cystic Fibrosis Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Cystic Fibrosis Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Cystic Fibrosis Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 72. Europe Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 74. South America Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Cystic Fibrosis Treatment Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
嚢胞性線維症用粘液クリアランスデバイスの世界市場 2020年 Market Overview The global Mucus Clearance Devices for Cystic Fibrosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The M…- 皮膚線維腫治療の世界市場 2020年 Market Overview The global Treatment of Skin Fibrosis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Treatment of Skin …
- 酒さ治療の世界市場 2020年 Market Overview The global Rosacea Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 1721.7 million by 2025, from USD 1526 million in 2019. The Rosacea Treatment ma…
- 軟骨無形成症治療の世界市場 2020年 Market Overview The global Achondroplasia Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Achondroplasia Treat…
- 不安障害及びうつ病治療の世界市場 2020年 Market Overview The Anxiety Disorder and Depression Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…